Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry

Status: Recruiting
Location: See all (29) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 1,000 patients and up to 50 sites.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: No
View:

• Subject or legally authorized representative provides written authorization and/or consent

• Subject who is to undergo thermal therapy by the NeuroBlate® System for treatment of their neurological disorder

Locations
United States
Arkansas
University of Arkansas for Medical Sciences
Recruiting
Little Rock
Arizona
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital & Medical Center
Recruiting
Phoenix
California
University of California, San Diego
Completed
La Jolla
Children's Hospital of Orange County
Recruiting
Orange
Connecticut
Yale University School of Medicine
Recruiting
New Haven
Florida
Advent Health Orlando
Recruiting
Orlando
The Cleveland Clinic Florida
Recruiting
Weston
Illinois
Northwestern University
Recruiting
Chicago
Kansas
University of Kansas Medical Center
Recruiting
Kansas City
Kentucky
Norton Cancer Institute
Recruiting
Louisville
University of Louisville
Recruiting
Louisville
Minnesota
University of Minnesota
Recruiting
Minneapolis
United Children's Hospital St. Paul
Completed
Saint Paul
Missouri
Washington University
Recruiting
Saint Louis
North Carolina
Duke University Medical Center
Recruiting
Durham
Wake Forest
Recruiting
Winston-salem
New York
Icahn School of Medicine at Mount Sinai
Recruiting
New York
New York University Langone Medical Center
Recruiting
New York
Weill Cornell Medicine
Withdrawn
New York
SUNY Upstate Medical University
Recruiting
Syracuse
Ohio
Cleveland Clinic Foundation
Recruiting
Cleveland
University Hospitals Cleveland Medical Center
Recruiting
Cleveland
Pennsylvania
Geisinger Medical Center
Recruiting
Danville
Thomas Jefferson University
Completed
Philadelphia
University of Pittsburgh Medical Center
Recruiting
Pittsburgh
Tennessee
Saint Thomas West Hospital and Research Institute
Recruiting
Nashville
Texas
University of Texas Southwestern Medical Center
Recruiting
Dallas
MD Anderson
Recruiting
Houston
Other Locations
Canada
University of British Columbia
Completed
Vancouver
Contact Information
Primary
Laura Menck
lmenck@monteris.com
Time Frame
Start Date: October 2015
Estimated Completion Date: December 2035
Participants
Target number of participants: 3000
Authors
Constantino Hadjipanayis, Steven Abram, Joffre Olaya, Mark Richardson, Joseph Petronio, Tiffany Hodges, Kris Smith, Hamid Borghei-Razavi, David Sun, Bradley Lega, Taylor Abel, Albert Kim, Fedor Panov, Joseph Neimat, Eric Leuthardt, Ganesh Rao, Patrick Landazuri, Kalil Abdullah, Michel Lacroix, James Baumgartner, Melvin Field, Analiz Rodriguez, Rohan Ramakrishna, David Piccioni, Kevin Judy, Clark Chen, Sujit Prabhu, Veronica Chiang, Andrew Sloan, Jospeh Petronio, Brian Williams, Zulma Tovar-Spinoza, Alireza Mohammadi, Peter Fecci, Brian Toyota, Stephen Tatter, Dimitris Placantonakis, Sylvia Kurz
Sponsors
Leads: Monteris Medical

This content was sourced from clinicaltrials.gov

Similar Clinical Trials